CCDC13
Coiled-coil domain-containing protein 13
Also known as: CCD13_HUMAN, FLJ25467
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYE1
- Gene
- CCDC13
- Ensembl
- ENSG00000244607
- Chromosome
- 3
- Canonical length
- 715 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Centriolar satellite,Basal body,Cytosol
OverviewNCBI Gene
Acts upstream of or within DNA damage response; cytoplasmic microtubule organization; and non-motile cilium assembly. Located in centriolar satellite. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
715 residues, UniProt reviewed canonical sequence.
>Q8IYE1|CCDC13
1 MAADESSQNT LRLQFKAMQE MQHKRLQKQM EKKREKELSL KSRADDQEEP LEVSDGLSLL
61 HAGEPNSKNS FEKRVLEDEI EHLRNELRET VDENGRLYKL LKERDFEIKH LKKKIEEDRF
121 AFTGTAGVAG DVVATKIVEL SKKNRLLMAE SEGAKTRVKQ LTNRIQELER ELQTALTRLS
181 AKGATDAGAK PPRAQMGDRA LLETPEVKAL QDRLVATNLK MSDLRNQIQS VKQELRMAQK
241 VLAREVGEDI NVQQLLSSPG TWRGRAQQIL VLQSKVQELE KQLGQARSQS AGTASDELSV
301 YPDPRKLSAQ EKNLLRIRSL EREKQEGLEK LASERDVLQR ELEELKKKFE GMRSRNKLLS
361 SEMKTLKSQM GTLVEKGRHD DELIDALMDQ LKQLQEILGS LSLQEEKTRV SQHHLDQQLN
421 SEAQRSNSLV AQLQAMVAER EAKVRQLEME IGQLNVHYLR NKGVGEGSSG REVSPAYTQF
481 LEDPGLTKSP ASAGDHVGRL GSSRSVTSLG HTLVESALTR PSLPSPHRTS PRFSDSPEQK
541 GWQAQVSEIK ALWQAAEVER DRLTEFVTVL QKRVEESNSK LLESERKLQE ERHRTVVLEQ
601 HLEKIRLEPG KASASQRAAP RTKTGLPTSN NRHNPTGSEK KDPSFAQLSD VPVESQMEEL
661 TTRLAIQVEE NEMLKAALGS ALRGKEEDFR MYHEILGQVK SVFLQALRQQ KTGKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCDC13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 4 nTPM
Expression across tissuesHPA
Tissue
- retina: 4 nTPM
- testis: 2.9 nTPM
- fallopian tube: 2.7 nTPM
- choroid plexus: 0.9 nTPM
- spinal cord: 0.9 nTPM
- hippocampal formation: 0.8 nTPM
Single-cell type
- ependymal cells: 69 nCPM
- choroid plexus epithelial cells: 20 nCPM
- epididymal efferent duct ciliated cells: 13 nCPM
- fallopian tube ciliated cells: 7.9 nCPM
- endometrial ciliated cells: 7.7 nCPM
- loop of henle epithelial cells: 7.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 5 nTPM
- white matter: 4.2 nTPM
- midbrain: 3.9 nTPM
- medulla oblongata: 3.8 nTPM
- basal ganglia: 3.3 nTPM
- cerebral cortex: 3.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Coiled-coil domain-containing protein 13
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CCDC13 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCDC13 as an antibody target. Whether an autoantibody or antibody against CCDC13 could matter depends on whether native CCDC13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCDC13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CCDC13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...